3-Aminobenzamide

3-Aminobenzamide

SCHEMBL27679552

NC(=O)c1cccc(N)c1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 1/20 0.63
PARP1 P09874 9/20 0.61
F2 P00734 1/20 0.59
PLG P00747 1/20 0.59
PRSS1 P07477 1/20 0.59
PRSS2 P07478 1/20 0.59
PRSS3 P35030 1/20 0.59
POLB P06746 2/20 0.54
TSHR P16473 2/20 0.54
CYP3A4 P08684 2/20 0.54
RECQL P46063 2/20 0.54
HSD17B10 Q99714 2/20 0.54
MAPT P10636 1/20 0.54
CYP2C19 P33261 1/20 0.54
BLM P54132 1/20 0.54
PMP22 Q01453 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
NPC1 O15118 1/20 0.53
MITF O75030 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Aminobenzamide SCHEMBL16070 1.00 PBRM1 (0.63) PBRM1PARP1F2PLGPRSS1
3-Aminobenzamide SCHEMBL8688920 0.98 F2 (0.63) PBRM1PARP1F2PLGPRSS1
3-Aminobenzamide SCHEMBL28015741 0.98 PBRM1 (0.61) PBRM1PARP1F2PLGPRSS1
3-Aminobenzamide SCHEMBL28944114 0.98 PBRM1 (0.61) PBRM1PARP1F2PLGPRSS1
SCHEMBL2909580 0.93 PARP1 (0.59) PBRM1PARP1F2PLGPRSS1
3-Aminobenzamide SCHEMBL28759683 0.92 PBRM1 (0.60) PBRM1PARP1F2PLGPRSS1
Terephthalic Acid SCHEMBL28053568 0.90 PBRM1 (0.58) PBRM1PARP1F2PLGPRSS1
3-Aminobenzamide SCHEMBL27579659 0.88 PARP1 (0.81) PBRM1PARP1F2PLGPRSS1
SCHEMBL3790485 0.87 ERN1 (0.54) PBRM1PARP1F2PLGPRSS1
3-Aminobenzamide SCHEMBL10277410 0.87 PBRM1 (0.55) PBRM1PARP1F2PLGPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 365 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3594323-B1 METHODS AND COMPOSITIONS FOR GENERATING PANCREATIC PROGENITORS AND FUNCTIONAL BETA CELLS FROM HPSCS UNIV HEALTH NETWORK (CA) 2026-05-27 EP claimed
WO-2026106998-A1 PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR AND RELATED COMPOSITION AND METHOD OF USE PURDUE RESEARCH FOUNDATION (US) 2026-05-21 WO claimed
EP-4683630-A1 VPS4B INHIBITOR FOR USE IN METHODS FOR THE TREATMENT OF HRD CANCER Institut Curie (FR) 2026-01-28 EP claimed
EP-4677083-A1 UNG/UDG INHIBITION IN BRCA-ASSOCIATED CANCER Institut Curie (FR) 2026-01-14 EP claimed
WO-2025109076-A1 BIOMARKERS FOR IDENTIFYING PATIENTS HAVING TUMORS WITH HOMOLOGOUS RECOMBINATION DEFICIENCY INSTITUT CURIE (FR) 2025-05-30 WO claimed
US-20250120963-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF THROMBOCYTOPENIA THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2025-04-17 US claimed
CN-115721261-B Knee joint movement function evaluation device based on plantar flexible sensing array 复旦大学 2024-11-29 CN claimed
EP-4452234-A1 CHEMOEMBOLIC COMPOSITIONS AND METHODS OF TREATMENT USING THEM Boston Scientific Medical Device Limited (IE) 2024-10-30 EP claimed
WO-2024216115-A1 METHODS FOR PRODUCING A SUPER CENTRAL MEMORY CD8 T CELL SUBTYPE BY POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITION AND USES THEREOF GEORGETOWN UNIVERSITY (US) 2024-10-17 WO claimed
WO-2024194401-A1 VPS4B INHIBITOR FOR USE IN METHODS FOR THE TREATMENT OF HRD CANCER INSTITUT CURIE (FR) 2024-09-26 WO claimed
CN-115721261-A Knee joint motor function evaluation device based on sole flexible sensing array 复旦大学 2023-03-03 CN claimed
EP-4127065-A1 COMPOSITIONS WHICH HAVE POLYESTER-POLYSILOXANE COPOLYMERS Wacker Chemie AG (DE) 2023-02-08 EP claimed
EP-4121564-A1 BIOMARKERS FOR SACITUZUMAB GOVITECAN THERAPY Immunomedics, Inc. (US) 2023-01-25 EP claimed
EP-4100030-A1 ONCOLYTIC VIRUS COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER City of Hope (US) 2022-12-14 EP claimed
WO-2022233782-A1 COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION LEAD DISCOVERY CENTER GMBH (DE) 2022-11-10 WO claimed
WO-2022168879-A1 FLUORESCENT MATERIAL, FLUORESCENT MEMBER, AND LIGHT-EMITTING MODULE 株式会社小糸製作所 2022-08-11 WO claimed
WO-2022098086-A1 METHOD FOR DETERMINING SENSITIVITY TO PARP INHIBITOR OR DNA DAMAGING AGENT USING NON-FUNCTIONAL TRANSCRIPTOME 한국과학기술원 2022-05-12 WO claimed
WO-2022048755-A1 COMPOSITIONS CONTAINING OXAMIDE-FUNCTIONAL SILOXANES WACKER CHEMIE AG (DE) 2022-03-10 WO claimed
WO-2022023381-A1 METHODS FOR IDENTIFYING CHROMOSOMAL SPATIAL INSTABILITY SUCH AS HOMOLOGOUS REPAIR DEFICIENCY IN LOW COVERAGE NEXT-GENERATION SEQUENCING DATA SOPHIA GENETICS S.A. (CH) 2022-02-03 WO claimed
EP-3080292-B1 METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS INST CURIE (FR) 2022-02-02 EP claimed